Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (PRINCE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02506140|
Recruitment Status : Unknown
Verified December 2017 by yongjun wang, Ministry of Science and Technology of the People´s Republic of China.
Recruitment status was: Active, not recruiting
First Posted : July 23, 2015
Last Update Posted : December 13, 2017
Ministry of Science and Technology of the People´s Republic of China
Beijing Municipal Science & Technology Commission
Information provided by (Responsible Party):
yongjun wang, Ministry of Science and Technology of the People´s Republic of China
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||June 10, 2017|
|Estimated Study Completion Date :||March 10, 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y; PRINCE Protocol Steering Group. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ. 2019 Jun 6;365:l2211. doi: 10.1136/bmj.l2211.
Wang Y, Lin Y, Meng X, Chen W, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Liu L, Zhao X, Wang Y; PRINCE Protocol Steering Group. Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design. Int J Stroke. 2017 Apr;12(3):321-325. doi: 10.1177/1747493017694390. Epub 2017 Jan 1.